The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Therapeutic Effect of Ibandronate Combined with Chemotherapy On Bone Metastases of Advanced Breast Cancer
Author(s): 
Pages: 617-618,621
Year: Issue:  6
Journal: THE PRACTICAL JOURNAL OF CANCER

Keyword:  乳腺癌骨转移伊班膦酸钠药物治疗;
Abstract: 目的观察伊班膦酸钠(艾本)联合化疗对乳腺癌骨转移的止痛效果和不良反应.方法将65例晚期乳腺癌并骨转移患者随机分为A、B 2个组,A组给予伊班膦酸钠4 mg,静脉滴注,每4周1次,连用2~4次,并给长春瑞宾25 mg/m2,静脉注射,第1、8天;表阿霉素50~70 mg/m2,静脉注射,第2天;每21~28天为1个周期,连用2~4个周期.B组为单用伊班膦酸钠,剂量和用法同A组.结果A、B 2组止痛有效率分别为87.5%(28/32)和81.3%(26/32),经统计学分析,元显著性差异(P>0.05);A组不良反应较B组多,主要是化疗后骨髓抑制及消化道反应.结论对乳腺癌骨转移性疼痛,采用伊班膦酸钠治疗,可获得较好的疗效,若再加化疗,并不能进一步提高近期镇痛效果.
Related Articles
loading...